Concepedia

Author

Arthur Machlenkin

Weizmann Institute of Science

Also Known As

A Machlenkin, A. Machlenkin, Arthur Machlenkin, Arthur Machlenkin (691789)

55

Publications

790

Citations

16

H-Index

33

Concepts

All Affiliations

Weizmann Institute of ScienceHadassah Medical CenterHebrew University of JerusalemBarzilai Medical CenterCompugen (Israel)
AM

About

Arthur Machlenkin is an author at Weizmann Institute of Science specializing in medicine, immunotherapy, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

284

2

Immunology

6

6

123

3

Cell Biology

4

4

234

4

Allergy

1

1

15

5

Cellular Therapies

1

1

23

Arthur Machlenkin

×

20

Publications

781

Citations

16

H-Index

YearCitations

1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage.

Amiram Ravid, Dafna Rocker, Arthur Machlenkin,

PubMed

1999

161

Combined Dendritic Cell Cryotherapy of Tumor Induces Systemic Antimetastatic Immunity

Arthur Machlenkin, Ofir Goldberger, Boaz Tirosh,

Clinical Cancer Research

2005

114

Human CTL Epitopes Prostatic Acid Phosphatase-3 and Six-Transmembrane Epithelial Antigen of Prostate-3 as Candidates for Prostate Cancer Immunotherapy

Arthur Machlenkin, Adrian Paz, Erez Bar Haim,

Cancer Research

2005

75

Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity

Benjamin Murter, Xiaoyu Pan, Eran Ophir,

Cancer Immunology Research

2019

56

Capture of Tumor Cell Membranes by Trogocytosis Facilitates Detection and Isolation of Tumor-Specific Functional CTLs

Arthur Machlenkin, Ronny Uzana, Shoshana Frankenburg,

Cancer Research

2008

41

A high‐throughput <scp>RNA</scp> i screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

Nisit Khandelwal, Marco Breinig, Tobias Speck,

EMBO Molecular Medicine

2015

40

Exuberated Numbers of Tumor-Specific T Cells Result in Tumor Escape

Ofir Goldberger, Ilan Volovitz, Arthur Machlenkin,

Cancer Research

2008

31

Trogocytosis Is a Gateway to Characterize Functional Diversity in Melanoma-Specific CD8+ T Cell Clones

Ronny Uzana, Galit Eisenberg, Yael Sagi,

The Journal of Immunology

2011

30

Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity <i>In Vivo</i>

Galit Eisenberg, Roni Engelstein, Anat Geiger-Maor,

Cancer Immunology Research

2018

29

Imprinting of Lymphocytes with Melanoma Antigens Acquired by Trogocytosis Facilitates Identification of Tumor-Reactive T Cells

Galit Eisenberg, Ronny Uzana, Aviad Pato,

The Journal of Immunology

2013

25

Page 1